Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

New early marker in Parkinson’s disease

Published on: 29/01/2014 Reading time: 1 min
Le complexe coeruleus/subcoeruleus est visible dans cette nouvelle sequence IRM. Cela nous a permis d’étudier la relation entre cette petite structure (en blanc dans l’image) et le tonus musculaire pendant le sommeil paradoxal.
Retour à la recherche

A paper published in the prestigious journal Brain by a team of the Institut du Cerveau - ICM institute link rapid eye movement sleep disorders and Parkinson’s disease. These results open the possibilities to early diagnose development of the Parkinson’s disease.

Parkinson disease is a progressive degenerative neurological disorder affecting 150 000 persons in France. It is characterized by the death of a neuronal population producing dopamine, a neurotransmitter, chemical messenger allowing transmission of informations between neurons. The diminution of the concentration of dopamine is the source of the development of the disease. Indeed, symptoms arise when 60-80% of these specific neurons disappear.

These last few years, researchers studied non-dopaminergic symptoms and more notably rapid eye movement sleep behavior disorder affecting 30 to 60% of patients. Rapid eye movement sleep is traditionally characterized by dreams and is associated with a strong neuronal activity, ocular movements and diminution of muscle tone. Some patients with Parkinson disease have rapid eye movement sleep behavior disorders with increased muscular tone which could lead to nocturnal violence. Rapid eye movement sleep behavior disorders could arise in any healthy subject whithout neurological disease. However, these persons present a higher risk to develop Parkinson disease or demencia. Daniel GarcÍa-Lorenzo in the team of Marie Vidailhet et Stéphane Lehéricy just highlighted the role of a part of the brain named the coeruleus/subcoeruleus complex in the blocking of muscle tone during eye rapid movement sleep.

The team studied the integrity of this complex in patients with Parkinson’s disease using imaging approaches. They showed that patients with Parkinson’s disease have a reduced neuronal activity in the coeruleus/subcoeruleus complex associated with rapid eye movement sleep behavior disorder. Imaging datas combined with careful clinical evaluation as well as nocturnal video monitoring may be used as an early marker of non-dopaminergic Parkison’s disease pathology to predict the occurrence of Parkinson’s disease.

Le complexe coeruleus/subcoeruleus est visible dans cette nouvelle sequence IRM. Cela nous a permis d’étudier la relation entre cette petite structure (en blanc dans l’image) et le tonus musculaire pendant le sommeil paradoxal.
The coeruleus/subcoeruleus complex is visible in this new MRI sequence. This allowed us to study the relation between these small structures (in white on the image) and the muscle tone during rapid eye movement sleep.

Sources

Garcia-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, Leu-Semenescu S, Gallea C, Quattrocchi G, Lobo PP, Poupon C, Benali H, Arnulf I, et al.: The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease. Brain 2013, 136:2120-2129.

Our news on the subject

TDAH : les troubles de l’attention sont associées à l’intrusion d’ondes du sommeil pendant l’éveil
ADHD: Attention difficulties are linked to the intrusion of sleep waves during wakefulness
Attention-deficit/hyperactivity disorder (ADHD) remains poorly understood from a biological perspective. An international study led by scientists from the Paris Brain Institute and Monash University in Australia suggests that some symptoms may be...
03.17.2026 Research, science & health
L’IRM structurelle ne permet pas, à elle seule, de diagnostiquer la dépression
Structural MRI alone cannot diagnose depression
Can brain imaging reveal whether a person is affected by depression? This question has driven research for many years. Changes in brain structure have indeed been observed in patients with depression, suggesting that structural MRI might one day help...
03.12.2026 Research, science & health
Épilepsie temporale : une nouvelle stratégie pour corriger l’activité électrique anormale
Temporal Lobe Epilepsy: A New Strategy to Correct Abnormal Electrical Activity
Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...
03.06.2026 Research, science & health
Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
See all our news